Profound Medical

PROF

Börsenwert 216 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Fidelity International Hamilton, Bermuda	10,6 Mio. $	+138.056 $	+20.000	+1 %
2	2 Gagnon Securities New York	9,9 Mio. $	+311.655 $	+45.149	+3 %
3	3 Letko, Brosseau & Associates Montreal, Quebec, Canada	5,92 Mio. $	-22.779 $	-3.300	-0,3 %
4	TIM 4 Timelo Investment Management Aurora, Ontario, Canada	5,77 Mio. $	+546.936 $	+79.234	+9 %
5	GA 5 Gagnon Advisors New York	5,22 Mio. $	–	–	–
6	6 Raymond James Financial St Petersburg, Florida	5,2 Mio. $	+118.521 $	+17.170	+2 %
7	7 Royce & Associates New York	4,35 Mio. $	-20.708 $	-3.000	-0,4 %
8	8 Rosalind Advisors Toronto, Ontario, Canada	4,03 Mio. $	–	–	–
9	MI 9 MMCAP International Grand Cayman, Cayman Islands	2,8 Mio. $	-63.098 $	-9.141	-2 %
10	10 Royal Bank of Canada Toronto, Ontario, Canada	2,54 Mio. $	+102.127 $	+14.795	+4 %
11	ACM 11 Altium Capital Management New York	2,1 Mio. $	-858.784 $	-124.411	-26 %
12	12 Ring Mountain Capital Tiburon, California	1,79 Mio. $	+200.858 $	+29.098	+10 %
13	13 Ardsley Advisory Partners Stamford, Connecticut	1,72 Mio. $	–	–	–
14	14 Picton Mahoney Asset Management Toronto, Ontario, Canada	1,47 Mio. $	+23.152 $	+3.354	+1 %
15	15 Formula Growth Montreal, Quebec, Canada	1,43 Mio. $	-27.439 $	-3.975	-2 %
16	16 Thompson Davis & Co Richmond, Virginia	1,19 Mio. $	+148.790 $	+21.555	+12 %
17	17 Bank of America Charlotte, North Carolina	1,18 Mio. $	–	–	–
18	18 Bleichroeder LP New York	1,07 Mio. $	–	–	–
19	19 Alyeska Investment Group Chicago, Illinois	931.200 $	–	–	–
20	20 Stonepine Capital Management Bend, Oregon	814.462 $	-414.568 $	-60.058	-30 %
21	21 National Bank of Canada Montreal, Quebec, Canada	666.825 $	+73.294 $	+10.618	+8 %
22	22 Citadel Advisors Miami, Florida	420.908 $	+181.060 $	+26.230	+57 %
23	23 Chilton Investment Company Stamford, Connecticut	378.300 $	-103.542 $	-15.000	-19 %
24	24 PenderFund Capital Management Vancouver, British Columbia, Canada	342.917 $	–	–	–
25	25 AYAL Capital Advisors Toronto, Ontario, Canada	291.000 $	–	–	–

Profound Medical PROF Börsenwert 216 Mio. $

Profound Medical

PROF

Börsenwert 216 Mio. $